BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2013
View Archived Issues
Minocycline may sensitize recurrent glioblastoma after bevacizumab failure
Read More
Buparlisib generally well tolerated in glioblastoma multiforme trial
Read More
Covagen secures series B financing to advance COVA-322
Read More
New phase II study to investigate MOR-208 with lenalidomide in CLL
Read More
Novel endochin-like quinolones as cytochrome bc1 inhibitors for Plasmodium infection
Read More
Soligenix begins phase II trial of SGX-942 for the treatment of oral mucositis
Read More
Astellas Pharma and Vical begin phase II trial of ASP-0113 CMV vaccine
Read More
EPOCH study of MK-8931 in Alzheimer's disease to continue after interim safety analysis
Read More
Incozen Therapeutics presents BIA-6 as a novel antitumor agent
Read More
Enanta Pharmaceuticals and AbbVie report data from phase III trial SAPPHIRE-II
Read More
Lundbeck and Otsuka set to codevelop Alzheimer's disease vaccine
Read More
NewLink Genetics begins phase I trial of NLG-919
Read More
Treatment phase of MGN-1703 safety trial completed
Read More
Verastem begins phase I trial of VS-5584 in solid tumors and lymphomas
Read More
Juventus studies retrograde infusion of gene therapy in patients with symptomatic heart failure
Read More
Dual BCR-ABL and MNK kinase inhibitors developed for blast crisis chronic myeloid leukemia
Read More
GlaxoSmithKline presents new tankyrase inhibitors for cancer
Read More
French researchers disclose novel mGlu2 receptor modulators
Read More
GlaxoSmithKline patents novel TYK2 inhibitors
Read More
Orion Corp. synthesizes new series of COMT inhibitors
Read More
IDE application submitted to the FDA for Gencaro companion diagnostic
Read More
Scientists at Convergence Pharmaceuticals synthesize new Na(v)1.7 blockers
Read More
Novel pim kinase inhibitors reported by Novartis for cancer and other disorders
Read More
KNG-I-484C described as novel candidate for NSCLC
Read More
FDA grants priority review to Cerdelga for Gaucher's disease
Read More
Synthetic Biologics investigates new approaches for IBS
Read More
Orexigen Therapeutics resubmits NDA for Contrave
Read More